Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chro...
Use this information to figure out if this company is an ideal customer for you.
877.223.6949
217 Country Club Park
Birmingham, 35213
11 - 50 Employees
$5M - $20M
linkedin.com/company/bridge-therapeutics-inc
The most common Bridge Therapeutics Inc. email format is [first] (ex. john@bridgetherapeutics.com), currently being used by 78% of Bridge Therapeutics Inc. business email addresses. There are 9 email formats used by Bridge Therapeutics Inc..
Bridge Therapeutics Inc.'s CEO is David H Bergstrom
Bridge Therapeutics Inc.'s HQ is located at 217 Country Club Park, Birmingham
Bridge Therapeutics Inc.'s phone number is 877.223.6949
Bridge Therapeutics Inc.'s official website is bridgetherapeutics.com
Bridge Therapeutics Inc.'s revenue is $5M - $20M
Bridge Therapeutics Inc. has 11 - 50 employees
Bridge Therapeutics Inc. is in the industry of: Pharmaceuticals
